Walleye Trading’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-95,800
Closed -$346K 4075
2025
Q4
$346K Buy
95,800
+87,600
+1,068% +$382K ﹤0.01% 3062
2025
Q3
$30.9K Sell
8,200
-22,200
-73% -$85.7K ﹤0.01% 4059
2025
Q2
$118K Buy
+30,400
New +$165K ﹤0.01% 3515
2025
Q1
Sell
-700
Closed -$5.05K 4004
2024
Q4
$5.05K Buy
+700
New +$5.35K ﹤0.01% 4079
2024
Q2
Sell
-1,100
Closed -$11.2K 4221
2024
Q1
$11.2K Buy
1,100
+1,000
+1,000% +$10.2K ﹤0.01% 4297
2023
Q4
$1.13K Hold
100
﹤0.01% 4901
2023
Q3
$260 Hold
100
﹤0.01% 4940
2023
Q2
$353 Hold
100
﹤0.01% 4631
2023
Q1
$422 Sell
100
-1,800
-95% -$21.4K ﹤0.01% 4755
2022
Q4
$31.3K Buy
+1,900
New +$21.3K ﹤0.01% 4296
2022
Q3
Sell
-100
Closed -$1K 4985
2022
Q2
$1K Buy
+100
New +$617 ﹤0.01% 4995
2022
Q1
Sell
-21,700
Closed -$199K 5263
2021
Q4
$199K Buy
+21,700
New +$231K ﹤0.01% 3864

Other funds holding ALT

Walleye Trading's ALT Position: Q4 2025 in Review

Walleye Trading sold out of Altimmune (ALT) in Q4 2025, closing a stake of 14,759 shares — an estimated $64.3K sold.

Walleye Trading first reported a position in ALT in Q3 2013 and held it in 16 quarters. The position peaked at $1.29M in Q4 2022. 181 funds tracked by Wall St. Rank hold ALT as of Q4 2025.

  • Walleye Trading reported no remaining Altimmune position as of Q4 2025 after selling out during the quarter.
  • Walleye Trading sold 14,759 Altimmune shares in Q4 2025, an estimated $64.3K.
  • Walleye Trading first reported a position in Altimmune in Q3 2013 and held it in 16 quarters.
  • Walleye Trading's Altimmune position peaked at $1.29M in Q4 2022.
  • 181 funds tracked by Wall St. Rank held Altimmune as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.